Clinical Significance of Pleiotropic Effects of Statins: Lipid Reduction and Beyond
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
1831-1850
Author(s):
J. Auer, R. Berent, T. Weber and B. Eber
HMG-Co A Reductase Inhibitors in the Treatment of Cardiovascular Diseases: Stabilization of Coronary Artery Plaque
Journal:
Current Drug Targets
Volume:
3
Page:
379-385
Author(s):
Ryuichi Morishita, Naruya Tomita and Toshio Ogihara
Proteoglycans in Inflammation
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
1
Page:
89-102
Author(s):
M. Delehedde, F. Allain, S. J. Payne, R. Borgo, C. Vanpouille, D. G. Fernig and E. Deudon
Molecular Views and Measurements of Hemostatic Processes Using Atomic Force Microscopy
Journal:
Current Protein & Peptide Science
Volume:
3
Page:
249-274
Author(s):
R. E. Marchant, I. Kang, P. S. Sit, Y. Zhou, B. A. Todd, S. J. Eppell and I. Lee
Aspartic Proteinases in Disease: A Structural Perspective
Journal:
Current Drug Targets
Volume:
3
Page:
155-173
Author(s):
J. B. Cooper
Chronic Tendon Pain: No Signs of Chemical Inflammation but High Concentrations of the Neurotransmitter Glutamate. Implications for Treatment?
Journal:
Current Drug Targets
Volume:
3
Page:
43-54
Author(s):
Hakan Alfredson and Ronny Lorentzon
Role of Biotransformation in Conceptal Toxicity of Drugs and Other Chemicals
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
833-857
Author(s):
Arun P. Kulkarni
Coagulation Factor Xa Inhibition: Biological Background and Rationale
Journal:
Current Topics in Medicinal Chemistry
Volume:
1
Page:
151-159
Author(s):
Robert J. Leadley and Jr.
Ceruloplasmin, the Unique Multi-Copper Oxidase of Vertebrates
Journal:
Protein & Peptide Letters
Volume:
8
Page:
159-169
Author(s):
Giovanni Musci
New Developments in Anti-Platelet Therapies Potential Use of CD39/Vascular ATP Diphosphohydrolase in Thrombotic Disorders
Journal:
Current Drug Targets
Volume:
1
Page:
285-296
Author(s):
Imrana Qawi and Simon C. Robson